Labcorp Holdings annual debt-to-equity ratio
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Debt-to-Equity Ratio Growth & History (LH)
Labcorp Holdings's debt-to-equity ratio was 0.76 for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.76 | −0.15 | −16.18% |
| 2024 | 2024-12-31 | 0.90 | 0.15 | +19.46% |
| 2023 | 2023-12-31 | 0.76 | 0.14 | +22.21% |
| 2022 | 2022-12-31 | 0.62 | 0.00 | +0.21% |
| 2021 | 2021-12-31 | 0.62 | −0.10 | −13.77% |
| 2020 | 2020-12-31 | 0.72 | −0.21 | −23.00% |
| 2019 | 2019-12-31 | 0.93 | 0.06 | +7.48% |
| 2018 | 2018-12-31 | 0.87 | −0.14 | −14.35% |
| 2017 | 2017-12-31 | 1.01 | −0.07 | −6.50% |
| 2016 | 2016-12-31 | 1.08 | −0.23 | −17.41% |
| 2015 | 2015-12-31 | 1.31 | 0.21 | +19.19% |
| 2014 | 2014-12-31 | 1.10 | −0.12 | −9.75% |
| 2013 | 2013-12-31 | 1.22 | 0.68 | +126.51% |
| 2012 | 2012-12-31 | 0.54 | −0.35 | −39.48% |
| 2011 | 2011-12-31 | 0.89 | −0.00 | −0.02% |
| 2010 | 2010-12-31 | 0.89 | 0.23 | +34.02% |
| 2009 | 2009-12-31 | 0.66 | −0.36 | −35.06% |
| 2008 | 2008-12-31 | 1.02 | — | — |
Labcorp Holdings quarterly debt-to-equity ratio
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.79 | 0.07 | +10.16% |
| Q1 2026 | 2026-03-31 | 0.83 | 0.04 | +5.71% |
| Q4 2025 | 2025-12-31 | 0.76 | −0.15 | −16.18% |
| Q3 2025 | 2025-09-30 | 0.69 | −0.08 | −10.36% |
| Q2 2025 | 2025-06-30 | 0.71 | 0.22 | +44.43% |
| Q1 2025 | 2025-03-31 | 0.78 | 0.29 | +59.06% |
| Q4 2024 | 2024-12-31 | 0.90 | 0.15 | +19.46% |
| Q3 2024 | 2024-09-30 | 0.77 | 0.10 | +14.06% |
| Q2 2024 | 2024-06-30 | 0.49 | −0.18 | −26.54% |
| Q1 2024 | 2024-03-31 | 0.49 | −0.19 | −27.64% |
| Q4 2023 | 2023-12-31 | 0.76 | 0.14 | +22.21% |
| Q3 2023 | 2023-09-30 | 0.68 | 0.06 | +9.16% |
| Q2 2023 | 2023-06-30 | 0.67 | 0.07 | +10.79% |
| Q1 2023 | 2023-03-31 | 0.68 | 0.10 | +16.21% |
| Q4 2022 | 2022-12-31 | 0.62 | 0.00 | +0.21% |
| Q3 2022 | 2022-09-30 | 0.62 | 0.02 | +3.98% |
| Q2 2022 | 2022-06-30 | 0.61 | −0.01 | −1.41% |
| Q1 2022 | 2022-03-31 | 0.59 | 0.00 | +0.35% |
| Q4 2021 | 2021-12-31 | 0.62 | −0.10 | −13.77% |
| Q3 2021 | 2021-09-30 | 0.60 | −0.21 | −26.35% |
| Q2 2021 | 2021-06-30 | 0.62 | −0.35 | −36.36% |
| Q1 2021 | 2021-03-31 | 0.58 | −0.43 | −42.34% |
| Q4 2020 | 2020-12-31 | 0.72 | −0.21 | −23.00% |
| Q3 2020 | 2020-09-30 | 0.81 | −0.22 | −21.13% |
| Q2 2020 | 2020-06-30 | 0.97 | −0.08 | −7.92% |
| Q1 2020 | 2020-03-31 | 1.01 | 0.05 | +5.73% |
| Q4 2019 | 2019-12-31 | 0.93 | 0.06 | +7.48% |
| Q3 2019 | 2019-09-30 | 1.03 | 0.13 | +14.29% |
| Q2 2019 | 2019-06-30 | 1.05 | 0.12 | +13.43% |
| Q1 2019 | 2019-03-31 | 0.96 | −0.02 | −2.10% |
| Q4 2018 | 2018-12-31 | 0.87 | −0.14 | −14.35% |
| Q3 2018 | 2018-09-30 | 0.90 | −0.29 | −24.42% |
| Q2 2018 | 2018-06-30 | 0.93 | −0.13 | −12.05% |
| Q1 2018 | 2018-03-31 | 0.98 | −0.08 | −7.46% |
| Q4 2017 | 2017-12-31 | 1.01 | −0.07 | −6.50% |
| Q3 2017 | 2017-09-30 | 1.19 | 0.08 | +6.93% |
| Q2 2017 | 2017-06-30 | 1.05 | −0.10 | −8.60% |
| Q1 2017 | 2017-03-31 | 1.06 | −0.19 | −15.39% |
| Q4 2016 | 2016-12-31 | 1.08 | −0.23 | −17.41% |
| Q3 2016 | 2016-09-30 | 1.11 | −0.29 | −20.55% |
| Q2 2016 | 2016-06-30 | 1.15 | −0.28 | −19.77% |
| Q1 2016 | 2016-03-31 | 1.25 | −0.34 | −21.45% |
| Q4 2015 | 2015-12-31 | 1.31 | 0.21 | +19.19% |
| Q3 2015 | 2015-09-30 | 1.40 | 0.30 | +27.68% |
| Q2 2015 | 2015-06-30 | 1.44 | 0.30 | +25.89% |
| Q1 2015 | 2015-03-31 | 1.59 | 0.38 | +31.65% |
| Q4 2014 | 2014-12-31 | 1.10 | −0.12 | −9.75% |
| Q3 2014 | 2014-09-30 | 1.10 | 0.06 | +5.73% |
| Q2 2014 | 2014-06-30 | 1.14 | 0.20 | +21.07% |
| Q1 2014 | 2014-03-31 | 1.21 | 0.37 | +44.69% |
| Q4 2013 | 2013-12-31 | 1.22 | 0.68 | +126.51% |
| Q3 2013 | 2013-09-30 | 1.04 | 0.06 | +6.04% |
| Q2 2013 | 2013-06-30 | 0.94 | 0.14 | +17.56% |
| Q1 2013 | 2013-03-31 | 0.84 | 0.02 | +2.38% |
| Q4 2012 | 2012-12-31 | 0.54 | −0.35 | −39.48% |
| Q3 2012 | 2012-09-30 | 0.98 | 0.20 | +25.55% |
| Q2 2012 | 2012-06-30 | 0.80 | 0.03 | +3.23% |
| Q1 2012 | 2012-03-31 | 0.82 | −0.10 | −11.08% |
| Q4 2011 | 2011-12-31 | 0.89 | −0.00 | −0.02% |
| Q3 2011 | 2011-09-30 | 0.78 | 0.19 | +31.55% |
| Q2 2011 | 2011-06-30 | 0.78 | 0.18 | +29.68% |
| Q1 2011 | 2011-03-31 | 0.92 | 0.30 | +49.25% |
| Q4 2010 | 2010-12-31 | 0.89 | 0.23 | +34.02% |
| Q3 2010 | 2010-09-30 | 0.59 | −0.10 | −14.13% |
| Q2 2010 | 2010-06-30 | 0.60 | −0.10 | −14.78% |
| Q1 2010 | 2010-03-31 | 0.62 | — | — |
| Q4 2009 | 2009-12-31 | 0.66 | −0.36 | −35.06% |
| Q3 2009 | 2009-09-30 | 0.69 | — | — |
| Q2 2009 | 2009-06-30 | 0.70 | — | — |
| Q4 2008 | 2008-12-31 | 1.02 | — | — |
Labcorp Holdings debt-to-equity ratio trends
Over the last five fiscal years, Labcorp Holdings's debt-to-equity ratio increased from 0.72 to 0.76, a change of 0.04. The latest reported quarter, Q2 2026, shows 0.79.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...